NextPlat Corp. (NASDAQ:NXPL) Short Interest Update

NextPlat Corp. (NASDAQ:NXPL) saw a significant increase in short interest during the month of February. As of February 27th, there was short interest totaling 518,283 shares, an increase of 227.4% from the February 12th total of 158,290 shares. Based on an average daily trading volume, of 1,458,650 shares, the short-interest ratio is currently 0.4 days. Currently, 3.5% of the shares of the company are short sold. Currently, 3.5% of the shares of the company are short sold. Based on an average daily trading volume, of 1,458,650 shares, the short-interest ratio is currently 0.4 days.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of NextPlat in a report on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, NextPlat currently has an average rating of “Sell”.

Hedge Funds Weigh In On NextPlat

An institutional investor recently bought a new position in NextPlat stock. Citadel Advisors LLC acquired a new stake in NextPlat Corp. (NASDAQ:NXPL) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 48,176 shares of the company’s stock, valued at approximately $40,000. Citadel Advisors LLC owned 0.19% of NextPlat as of its most recent SEC filing. 1.30% of the stock is owned by hedge funds and other institutional investors.

NextPlat Stock Performance

Shares of NASDAQ:NXPL traded down $0.01 during trading on Thursday, reaching $0.44. 884,199 shares of the stock were exchanged, compared to its average volume of 1,611,496. NextPlat has a 12 month low of $0.41 and a 12 month high of $1.11. The stock has a 50-day moving average price of $0.59 and a 200-day moving average price of $0.68. The company has a current ratio of 3.56, a quick ratio of 2.80 and a debt-to-equity ratio of 0.04. The firm has a market cap of $11.95 million, a PE ratio of -1.48 and a beta of 1.26.

NextPlat Company Profile

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.